Global Payments Inc vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Global Payments Inc trades at $80.89 (market cap $21.67B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B). The key difference: Global Payments Inc is far larger — about 5.2× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Global Payments Inc pays a 1.22% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global Payments Inc for 50 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.
| GPN | INDV | |
|---|---|---|
Market Cap | $21.67B | $4.18B |
Volume | 1,851,678 | 1,819,746 |
Sector | Financials | Health |
52-Week High | $94.83 | $41.83 |
52-Week Low | $62.47 | $24.09 |
Typical Hold Time | 50 Days | 0 Days |
Enterprise Value | $39.81B | $4.47B |
Dividend Yield | 1.22% | — |
Signals from Pluang's Aura AI — not financial advice
Global Payments (GPN) trades at $80.89, down 1.43% on the day, with a neutral technical outlook despite recent earnings beats. The company shows strong revenue growth momentum with Q2 2026 EPS of $3.46 beating estimates, while maintaining a P/E of 38.81 and P/B below 1.0. Recent developments include the Genius platform rollout and Worldpay integration driving business expansion.
The stock offers 27% upside to the $102.75 consensus price target with strong analyst support (59% buy ratings), though negative net income margin and rising debt-to-asset ratio to 41.57% present execution risks. Key catalysts include continued Genius adoption while competition and cost pressures remain headwinds.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares.
Read more on GPN →Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →